Loading company…
Shanghai biotech in immunology, providing tissue storage, immunotherapy evaluation and immune-mediated disease testing.
Established in 2011 and based in Shanghai, China, Tissue Bank develops transplantation immunotherapy technology and works across immunology research, tissue storage, immunotherapy evaluation and diagnostic reagents. It provides testing for immune-mediated diseases, including clinical blood and body fluid tests and cell molecular genetics tests. Branches are in Shenzhen and Xi'an, and the company closed a Series D round in December 2018. Chairman and founder Zhongzheng Zheng graduated from Xiamen University.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in